In a study comprised of 3,879 bladder cancer patients, researchers found that 3.6 percent of said patients were diagnosed with VTE within one month of surgical admission. This number increased to 4.7 percent at two months and 5.4 percent at three months. Fifty-five percent of these VTE events happened after the patients had been discharged. Patients who undergo this procedure typically no longer receive prophylactic drug treatment to decrease the risk of VTE post-discharge.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The study affirmed prior knowledge about the rates of VTE in this particular patient-population. The amount of patients diagnosed after hospital discharge surprised the study’s authors. The researchers identified few predicative factors in patients who experienced VTE. The study’s findings suggest most patients undergoing bladder cancer surgery should receive extended VTE prophylaxis treatment.
More articles on quality:
App uses tweets to track, pinpoints food poisoning outbreaks
2% of US employees go to work sick every week
49 companies sign Patient Safety Movement’s Open Data Pledge
